132 related articles for article (PubMed ID: 9594875)
21. Prognostic relevance of the endothelial marker CD 34 in ovarian cancer.
Heimburg S; Oehler MK; Papadopoulos T; Caffier H; Kristen P; Dietl J
Anticancer Res; 1999; 19(4A):2527-9. PubMed ID: 10470188
[TBL] [Abstract][Full Text] [Related]
22. Effect of mast cells on tumor angiogenesis in lung cancer.
Tomita M; Matsuzaki Y; Onitsuka T
Ann Thorac Surg; 2000 Jun; 69(6):1686-90. PubMed ID: 10892907
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer.
Cox G; Walker RA; Andi A; Steward WP; O'Byrne KJ
Lung Cancer; 2000 Sep; 29(3):169-77. PubMed ID: 10996419
[TBL] [Abstract][Full Text] [Related]
24. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
[TBL] [Abstract][Full Text] [Related]
25. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer.
Chen F; Takenaka K; Ogawa E; Yanagihara K; Otake Y; Wada H; Tanaka F
Clin Cancer Res; 2004 Dec; 10(24):8548-53. PubMed ID: 15623638
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of angiogenesis in non-small cell lung carcinoma by CD34 immunohistochemistry.
Bing Z; Jian-ru Y; Yao-quan J; Shi-feng C
Cell Biochem Biophys; 2014 Sep; 70(1):327-31. PubMed ID: 24676677
[TBL] [Abstract][Full Text] [Related]
27. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
Offersen BV; Pfeiffer P; Hamilton-Dutoit S; Overgaard J
Cancer; 2001 Apr; 91(8):1500-9. PubMed ID: 11301398
[TBL] [Abstract][Full Text] [Related]
28. A biological staging model for operable non-small cell lung cancer.
Cox G; Jones JL; Andi A; Waller DA; O'Byrne KJ
Thorax; 2001 Jul; 56(7):561-6. PubMed ID: 11413356
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of microvascularization in cases of operated lung cancer.
Szöke T; Kayser K; Baumhäkel JD; Trojan I; Furak J; Tiszlavicz L; Eller J; Boda K
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1106-11. PubMed ID: 15896626
[TBL] [Abstract][Full Text] [Related]
30. CD34 as a marker for evaluating angiogenesis in cervical cancer.
Vieira SC; Silva BB; Pinto GA; Vassallo J; Moraes NG; Santana JO; Santos LG; Carvasan GA; Zeferino LC
Pathol Res Pract; 2005; 201(4):313-8. PubMed ID: 15991838
[TBL] [Abstract][Full Text] [Related]
31. Tumor angiogenesis in human lung adenocarcinoma.
Yamazaki K; Abe S; Takekawa H; Sukoh N; Watanabe N; Ogura S; Nakajima I; Isobe H; Inoue K; Kawakami Y
Cancer; 1994 Oct; 74(8):2245-50. PubMed ID: 7522947
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast Growth Factor Receptor 1 (FGFR1), Partly Related to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) and Microvessel Density, is an Independent Prognostic Factor for Non-Small Cell Lung Cancer.
Pu D; Liu J; Li Z; Zhu J; Hou M
Med Sci Monit; 2017 Jan; 23():247-257. PubMed ID: 28088809
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.
Bochner BH; Cote RJ; Weidner N; Groshen S; Chen SC; Skinner DG; Nichols PW
J Natl Cancer Inst; 1995 Nov; 87(21):1603-12. PubMed ID: 7563203
[TBL] [Abstract][Full Text] [Related]
34. Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features.
Toomey D; Smyth G; Condron C; Kay E; Conroy R; Foley D; Hong C; Hogan B; Toner S; McCormick P; Broe P; Kelly C; Bouchier-Hayes D
Cancer; 2001 Nov; 92(10):2648-57. PubMed ID: 11745200
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
[TBL] [Abstract][Full Text] [Related]
36. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma.
Tanigawa N; Matsumura M; Amaya H; Kitaoka A; Shimomatsuya T; Lu C; Muraoka R; Tanaka T
Cancer; 1997 Jan; 79(2):220-5. PubMed ID: 9010094
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
Takanami I
Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis in non-small cell lung cancer: microvessel area in needle biopsy in vascular tumor density.
Irion LC; Prolla JC; Hartmann AA; Irion KL; Da Silva VD
Anal Quant Cytol Histol; 2008 Apr; 30(2):83-91. PubMed ID: 18561744
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
[TBL] [Abstract][Full Text] [Related]
40. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
